Bio-Rad Laboratories Inc (BIO)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 9,364,100 10,603,500 9,688,450 12,609,900 12,299,100 11,895,900 11,978,200 13,667,400 13,501,700 12,058,500 12,682,100 14,373,700 17,775,800 19,953,400 15,117,600 13,933,200 12,972,600 12,020,900 10,097,300 8,684,360
Total stockholders’ equity US$ in thousands 6,569,300 7,487,860 6,778,790 9,051,130 8,741,130 8,416,200 8,446,890 9,763,720 9,615,250 8,453,600 8,922,600 10,182,900 13,667,100 15,332,400 11,594,900 10,609,100 9,879,940 8,825,140 7,353,400 6,293,080
Financial leverage ratio 1.43 1.42 1.43 1.39 1.41 1.41 1.42 1.40 1.40 1.43 1.42 1.41 1.30 1.30 1.30 1.31 1.31 1.36 1.37 1.38

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $9,364,100K ÷ $6,569,300K
= 1.43

The financial leverage ratio for Bio-Rad Laboratories Inc has exhibited a relatively stable trend over the period from March 31, 2020, to December 31, 2024, fluctuating between 1.30 and 1.43. This ratio indicates the level of debt financing used by the company compared to its equity. A higher financial leverage ratio suggests that a larger proportion of the company's assets are funded by debt, indicating higher financial risk.

Bio-Rad's financial leverage ratio showed a slight decline from 1.38 on March 31, 2020, to 1.31 on December 31, 2020. However, the ratio remained relatively consistent around 1.30 from March 31, 2021, to December 31, 2023, signaling a stable debt-to-equity mix. Subsequently, the ratio experienced a slight increase to 1.43 on June 30, 2024, followed by some fluctuations around this level.

Overall, the financial leverage ratio suggests that Bio-Rad Laboratories Inc has maintained a relatively balanced mix of debt and equity in its capital structure during the analyzed period, with a slight uptrend in recent periods. It is important for investors and stakeholders to monitor this ratio to assess the company's ability to meet its financial obligations and manage potential risks associated with leverage.